Shing-Yin Tsui
Keine laufenden Positionen mehr
Profil
Shing-Yin Tsui worked as Vice President & Corporate Controller at Dendreon Corp.
from 1999 to 2015, and as Secretary, Chief Accounting Officer & SVP-Finance at PhaseRx, Inc. from 2015 to 2017.
Tsui obtained an undergraduate degree from the University of Washington.
Ehemalige bekannte Positionen von Shing-Yin Tsui
| Unternehmen | Position | Ende |
|---|---|---|
| PHASERX, INC. | Finanzdirektor/CFO | 15.09.2017 |
| DENDREON CORPORATION | Comptroller/Controller/Auditor | 01.01.2015 |
Ausbildung von Shing-Yin Tsui
| University of Washington | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHASERX, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
